| value |
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1422142/0001995275-26-000008.txt","as_of":"2026-04-09T03:12:49.786272+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1422142/0001995275-26-000008.txt","company":"Whitehawk Therapeutics, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1422142/0001995275-26-000008.txt","article_chars":2089,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_be693d4ff25c81d8","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1422142/0001995275-26-000008.txt","content_type":"text/plain","enriched_at":"2026-04-09T13:36:51.706758+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1422142/0001995275-26-000008.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1422142/0001995275-26-000008.txt","source_event_id":"evt_5883e3104610","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"2b77c25cd996fabe","kind":"sec_filing","published_at":"20260408","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.72,"dates_mentioned":["2026-04-06","2026-04-07","2026-04-08","2026-04-09T03:12:49.786272+00:00","2026-04-08"],"entities":[{"asset_class":"equity","name":"Whitehawk Therapeutics, Inc.","relevance":"high","symbol":"WHWK","type":"issuer"},{"asset_class":"person","name":"Lennon David James","relevance":"high","symbol":"","type":"reporting_person"},{"asset_class":"person","name":"Stephen Rodin","relevance":"medium","symbol":"","type":"signatory"}],"event_type":"listing","information_gaps":["The signal is labeled \"discovery_sec_filing_delta\" but no prior known state or earlier filing details are provided, so the \"what changed vs prior\" portion cannot be determined from the provided text.","The text does not explicitly state whether the reported transactions are sales only versus any purchases; it only includes a statement that the transactions represent broker-assisted sales.","No total shares across all dates are explicitly summed in the text.","No explanation of the number of shares remaining after the transactions is included in the provided excerpt."],"key_facts":["SEC filing is Form 4 (CONFORMED SUBMISSION TYPE: 4).","Issuer: Whitehawk Therapeutics, Inc. (WHWK).","Reporting person: Lennon David James (OWNER DATA: COMPANY CONFORMED NAME: Lennon David James).","Filing accession number: 0001995275-26-000008; filed as of date: 2026-04-08; conformed period of report: 2026-04-06.","The Form 4 includes multiple common stock transaction entries dated 2026-04-06, 2026-04-07, and 2026-04-08 with share amounts shown in the text (102395, 94087, 63945).","The text states: \"Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.\"","The filing is signed: \"/s/ Stephen Rodin, as Attorney-in-Fact\" with date 2026-04-08."],"numeric_claims":[{"label":"Shares sold (2026-04-06 entry)","value":"102395"},{"label":"Shares sold (2026-04-07 entry)","value":"94087"},{"label":"Shares sold (2026-04-08 entry)","value":"63945"},{"label":"Price per share (2026-04-06 entry)","value":"3.51"},{"label":"Price per share (2026-04-07 entry)","value":"3.43"},{"label":"Price per share (2026-04-08 entry)","value":"3.4"}],"primary_claim":"On 2026-04-08, reporting person Lennon David James reported broker-assisted sales of Whitehawk Therapeutics common stock (WHWK) for tax withholding obligations tied to vested restricted stock units.","relevance_score":0.45,"sentiment":"neutral","source_quality":"medium","summary":"Whitehawk Therapeutics, Inc. (WHWK) filed a Form 4 on 2026-04-08 reporting broker-assisted sales of common stock by reporting person Lennon David James to satisfy tax withholding obligations related to vested restricted stock units.","topics":["SEC Form 4","insider transaction","restricted stock units","tax withholding","broker-assisted sale"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 Whitehawk Therapeutics, Inc. \u00b7 Filed 20260408","ticker":"WHWK","tickers":["WHWK"],"title":"WHWK filed 4","url":"https://www.sec.gov/Archives/edgar/data/1422142/0001995275-26-000008.txt"}... |